Mike Feehan
Analyst · BMO Capital Markets. Please go ahead
Thank you, Kurt. Good morning. Our stronger than anticipated first quarter results were largely driven by the favorable sales timing within the Zeolyst joint venture that Kurt referenced. While adjusted EBITDA for Ecoservices came in toward the lower end of our guidance range, we saw a favorable customer-driven shift in sales timing into the first quarter for hydrocracking and specialty catalyst, helping drive more favorable results in the quarter compared to our initial guidance. Total sales for the first quarter, including our proportionate 50% share of sales from the zealous joint venture, were $200 million, up nearly 9%, with sales of Ecoservices and advanced silicas each up 1%, and sales for the Zeolyst joint venture up 60%. Adjusted EBITDA for the first quarter was $39 million, led by the higher volume in the Zeolyst joint venture, largely offset by lower earnings in Ecoservices related to the higher planned turnaround costs and lower sales volume associated with turnaround activity. Turning to Slide 10, I'll highlight the major components of the change in adjusted EBITDA for the first quarter. Sulfur costs increased approximately $7 million quarter over quarter, which were passed through in price, resulting in no material impact to adjusted EBITDA. The $2 million unfavorable net price impact, when combining price and variable costs, was primarily driven by the timing and contractual pass-through of certain costs, including energy and other index costs within Ecoservices. Volume and mix were favorable, driven by the higher sales volume in the Zeolyst joint venture, partially offset by lower volume in Ecoservices as a result of the turnaround activity at our sites and our customers' facilities. The remaining other component primarily represents increased manufacturing costs in Ecoservices associated with planned turnaround costs, less favorable absorption of fixed costs associated with inventory timing, and general inflation. I'll now turn to segment highlights in the first quarter, starting with Ecoservices. Sales of a $143 million were up 1% compared to the first quarter of 2024. Included in the period over period change in sales was approximately $7 million of higher pricing associated with the pass-through of higher sulfur costs, as well as favorable contractual pricing for regeneration services. It was partially offset by the pass-through of lower energy and other index costs. These price factors were largely offset by lower sales volume related to the higher turnaround activity during the quarter at our sites as well as our customers' facilities. Adjusted EBITDA was $29 million compared to $42 million in the year-ago quarter. The lower adjusted EBITDA reflects approximately $8 million associated with higher manufacturing costs associated with planned turnarounds, the timing of fixed cost absorption and general inflation, approximately $3 million of lower sales volume, and approximately $2 million of unfavorable net pricing on the timing and contractual pass-through of certain costs. Within our advanced materials and catalyst segment, sales for advanced silicas were $19 million, with higher sales of niche custom catalysts largely offset by lower sales of advanced silicas used in the production of polyethylene, as customers pulled orders into the fourth quarter of 2024. Our proportionate 50% share of sales from the Zeolyst joint venture were up $14 million, with higher sales of hydrocracking and specialty catalysts more than offsetting lower sales of materials used in emission control applications and the timing of sales into customized catalyst applications. First quarter sales from the Zeolyst joint venture were higher than previously anticipated due to customer-driven sales timing. As our overall full-year expectations for advanced materials and catalysts have not changed, we have rebalanced our view of sales timing for the remainder of the year, and I'll provide more detail on our expectations by quarter in a few minutes. First quarter adjusted EBITDA was $17 million, up $6 million, primarily due to the higher sales volume within the Zeolyst joint venture. Switching over to cash and leverage on the next slide, on a full-year basis, we still expect to generate adjusted free cash flow of $60 to $80 million. However, due to the expected timing of dividends from the Zeolyst joint venture and the higher planned capital expenditures, including the ongoing capacity expansion in Kansas City, our adjusted free cash flow was a use of $13 million for the first quarter. We ended the first quarter with $127 million of cash, and our total liquidity was $201 million, including availability under our recently amended and extended ABL facility. We ended the quarter with a net debt ratio of 3.2 times, up slightly from the year end driven by lower adjusted EBITDA on a trailing 12-month basis. Previously noted, we expect to close the acquisition of the Cornerstone Sulfuric Acid assets in the second quarter, funding the $35 million acquisition through cash on hand. As Kurt discussed, in light of our current share price and associated valuation, we firmly believe that opportunistic share repurchases are a prudent and value-enhancing use of capital. And while taking a more opportunistic approach to share repurchases will likely defer near-term achievement of our target leverage ratio of 2 to 2.5 times, we would anticipate ending 2025 with a leverage ratio consistent with the end of the prior year of around 3 times. In addition, we continue to be extremely comfortable with our current capital structure and leverage profile, given the resilient nature of our businesses, our projected cash generation, and the fact that we refinanced our term loan last year, reducing the interest rate and extending the maturity to 2031, and then further reducing the interest rate by another 25 basis points through a repricing of the term loan earlier this year. I will now shift to a discussion of our outlook for the remainder of 2025. Our first quarter results provided a strong start to the year compared to our original expectations. While the fundamentals of our business remain strong and we expect our core businesses to remain stable, given the volatile macroeconomic environment, we are cautious about the potential for weaker demand in industrial end uses and for near-term softness in utilization rates for polyethylene producers. In terms of full-year guidance, we now expect our sales to be higher by $30 million in a range of $785 to $845 million, driven by an increase in the estimated pass-through effect related to higher expected sulfur costs for 2025. Excluding the higher estimated pass-through effect of higher sulfur costs on sales, our outlook for Ecoservices remains unchanged. For advanced silicas, we continue to expect sales growth over 2024 levels. While we previously guided the higher sales of polyethylene catalysts to outpace global demand growth, we remain cautious on the potential secondary effects of tariffs and the macroeconomic conditions on polyethylene. For the Zeolyst joint venture, although first-quarter sales were higher than originally anticipated due to a positive shift in sales timing, our full-year view has not changed, and we are maintaining our previously communicated guidance ranges. However, we have observed further positivity in the sales of hydrocracking catalysts, potentially providing additional upside to our current forecast and offsetting any softer sales in advanced silicas. Our original guidance range for 2025 incorporated what we believe to be an appropriate level of conservatism. Taking into consideration the effect of increased tariffs, we are maintaining our prior guidance for adjusted EBITDA, expecting it to be in the range of $238 to $258 million for the year. I'll note that our full-year guidance does not include any contribution from the pending acquisition of the Cornerstone Sulfuric Acid assets. Assuming a second-quarter close, while the acquisition is expected to provide incremental sales and contribution margin for the balance of the year, we anticipate incurring additional costs for integration and upgrading the facility, including a potential turnaround and additional capital expenditures. As such, we do not expect the earnings from this acquisition to be meaningful in 2025. We do expect the incremental adjusted EBITDA contribution of the acquired assets will be more material beginning in 2026. I'll now turn to specific guidance for the second quarter. We expect second-quarter adjusted EBITDA for Ecoservices to fall in the range of $47 million to $53 million. The sequential increase from the first quarter reflects higher projected sales volume associated with lower turnaround activity and seasonally stronger demand for regeneration services as we move into the summer driving season. For advanced materials and catalysts, given the positive shift in sales timing that benefited our first-quarter results, with some sales pulled forward from the second quarter into the first quarter, we now expect second-quarter adjusted EBITDA to be in the range of between $6 million to $10 million. Assuming unallocated corporate expense of approximately $8 million for the second quarter, we expect consolidated adjusted EBITDA to be in the range of $45 million to $55 million. Slide 15 provides detailed commentary on the directional guidance for the third and fourth quarters. I'll highlight a few key points. As discussed on our year-end call, we anticipate our earnings to be more heavily weighted toward the second half of the year. We expect the third quarter of 2025 to represent the peak quarter for both Ecoservices and advanced materials and catalysts, led by strong year-over-year volume growth for regeneration services and favorable contractual pricing in Ecoservices and higher expected sales of hydrocracking catalysts and sales of materials used in sustainable fuel production in advanced materials and catalysts compared to the third quarter of 2024. Looking at the fourth quarter, in Ecoservices, we expect regeneration services and virgin sulfuric acid volume to be in line with the fourth quarter of 2024, but with stronger pricing for both, driven by contractual price increases and higher demand in certain end uses. For advanced materials and catalysts, we expect stronger sales in advanced silicas, primarily for niche custom catalysts, including biocatalysis applications, but expect lower sales within the Zeolyst joint venture, reflective of order timing. In addition, included in our earnings presentation, we have provided a schedule reflecting planned turnarounds by quarter through 2026. Turnarounds for individual units are often performed every 18 months. It can vary depending upon several factors, including coordinating the timing with our customers' planned turnarounds. And while the scope and cost can vary for each, this schedule reflects our current estimate of the number of units requiring turnarounds by quarter. I'll now turn the call back to Kurt for some closing remarks.